Research and Markets: Endovascular Aneurysm Repair Market Report 2014 - Concise Analysis of the $3 Billion Industry

Research and Markets (http://www.researchandmarkets.com/research/hnqn27/endovascular) has announced the addition of the "Endovascular Aneurysm Repair Market" report to their offering.

Industry boundaries are imaginary lines arbitrarily drawn along technologies, markets and target customer lines to aid analysis needs of planners and strategists operating within the defined segment.

The market for endovascular aneurysm repair, regardless of location, lends itself readily to such a definition of a well defined market that has already exceeded $3 billion in annual revenue and is well on its way to achieve $5 billion in annual sales before the end of 2020.

Capitalizing on recent research on the endothelial homeostasis hypothesis of aneurysm initiation, progression and rupture, Medtech Ventures' analysts have developed a unique new way of looking at the endovascular aneurysm repair market that allows strategists to devise new ways of expanding their product lines, fortify their market positions, acquire relevant innovative start-ups and expand the total size of the pie for all involved.

With heightened acquisition activity, the endovascular aneurysm repair market is already consolidating at a breakneck speed, however with the recent successful IPOs of TriVascular (NASDAQ:TRIV) and Lombard Medical (NASDAQ:EVAR) the market is gearing for a new dynamic phase.

The Endovascular Aneurysm Repair report, which is targeted at senior executives, explores the landscape of an expanded space that encompass aortic, cerebral and peripheral aneurysms.

The report maps the competitive landscape in the newly envisioned market space, profiles leading companies strategic positions as well as innovative start-up offerings. It also volunteers suggestions towards high value chain consolidation scenarios beneficial to all.

Recent acquisition deals and IPO activities are profiled and valuation metrics are provided for the brave heart among stakeholders who wish to continue with the acquisition spree to further consolidate this potentially lucrative high stakes market and to set the research and development agenda for a new generation of products that could bridge both the medical device and the biotech realms.

Key Topics Covered:

1. Global Endovascular Aneurysm Repair Market Analysis

2. Anatomical Segmentation

2.1 Global Aortic Endovascular Aneurysm Repair Market

2.2 Global Cerebral Endovascular Aneurysm Repair Market

2.3 Global Peripheral Endovascular Aneurysm Repair Market

3. Leading Companies Strategic Positions & Device Offerings

3.1 Medtronic

3.2 Gore

3.3 Cook

3.4 Stryker

3.5 Covidien

3.6 Terumo

3.7 Johnson & Johnson

3.8 Endologix

3.9 TriVascular

4. Leading Companies Market Shares

5. Recent Acquisitions & Future Acquisition Opportunities

5.1 Recent Acquisitions in the Space & Their Valuation Metrics

5.2 Recent IPOs in the Space & Their Current Valuations

5.3 Innovative Startups & Their Technologies

5.4 Potentially Synergistic Future Acquisition Deals

6. Geographic Segmentation

6.1 US Endovascular Aneurysm Repair Market

6.2 European Endovascular Aneurysm Repair Market

6.3 Japanese Endovascular Aneurysm Repair Market

6.4 Chinese Endovascular Aneurysm Repair Market

6.5 Latin America Endovascular Aneurysm Repair Market

7. Technology Update

7.1 Endothelial Homeostasis Hypothesis

7.2 Hemodynamic Modulation Technology

7.3 Novel Biological Therapeutic Targets

7.4 Current Status of Endovascular Aortic Aneurysm Repair

7.5 Current Status of Endovascular Cerebral Aneurysm Repair

7.6 Current Status of Endovascular Peripheral Aneurysm Repair

8. Endovascular Aneurysm Repair Market Forecast

For more information visit http://www.researchandmarkets.com/research/hnqn27/endovascular

Contacts:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.